BIO TECH

AbbVie Buys Apogee Therapeutics for $10.9B. Is Big Phar..

AbbVie is acquiring Apogee Therapeutics for $10.9 billion in a high-stakes bet on zumilokibart, a promising eczema drug candidate that has caught Wall...

Relay Drug Shows Early Promise against Rare Blood Vesse..

Relay Therapeutics reported early clinical trial results showing its targeted therapy drug shrank tumors in patients with rare blood vessel cancers. T...

Merck antibody-drug conjugate (ADC) Trial Succeeds in F..

Merck‘s antibody-drug conjugate (ADC) licensed from China succeeded in a Phase 3 trial for non-small cell lung cancer. The Silicon Review report...

Midsize Biotechs Form Coalition to Fight Trump's MFN Dr..

Ten midsize biotech companies launched the Midsized Biotech Alliance of America to combat the Trump administration's Most Favored Nation drug pricing ...

FDA Accepts Moderna Flu Vaccine Filing After Swift Reth..

The FDA reversed course and accepted Moderna's revised mRNA flu vaccine application just eight days after a refusal, with an August 2026 decision dead...